Related Experiment Video
Updated: Aug 19, 2025

08:49
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
928
Atrial Standstill in the Pediatric Population: A Multi-Institution Collaboration
Taylor S Howard1, David Y Chiang2, Scott R Ceresnak3
1Department of Pediatrics, Division of Pediatric Cardiology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
JACC. Clinical Electrophysiology
|November 26, 2022
Summary
Atrial standstill (AS) is linked to SCN5A gene variants, causing arrhythmias and device challenges. Patients lacking atrial pacing need anticoagulation to prevent thromboembolic events.
Area of Science:
- Cardiology
- Genetics
- Pediatric Electrophysiology
Background:
- Atrial standstill (AS) is a rare condition with limited prior research.
- Characterized by a complete absence of electrical activity in the atria.
Purpose of the Study:
- To investigate the clinical features, genetic underpinnings, and patient outcomes in pediatric atrial standstill.
- To identify risk factors and management strategies for AS.
Main Methods:
- Retrospective multicenter study of patients under 18 years diagnosed with AS.
- Defined AS by absence of atrial activity confirmed via electrophysiology, device placement, or rhythm tracings and echocardiogram.
- Excluded acquired causes; collected clinical data and genetic variants.
Main Results:
- Diagnosed in 20 pediatric patients (median age 6.6 years).
- High prevalence of atrial/supraventricular arrhythmias (80%) and ventricular tachycardia (40%), with 4 cardiac arrests.
- SCN5A variants identified in 65% of patients; biallelic variants linked to ventricular arrhythmias and cardiac arrest.
- 90% required pacemakers, with challenges in achieving atrial pacing (4/15).
- 35% experienced thromboembolic events, primarily in those not on anticoagulation.
Conclusions:
- Atrial standstill is associated with SCN5A loss-of-function variants.
- Patients present with complex arrhythmias and device implantation difficulties.
- Risk of thromboembolic events necessitates anticoagulation in patients unable to achieve atrial pacing.

